Long term prognostic value of Nottingham histological grade and its components in early (pT1 N0M0) breast carcinoma

被引:61
作者
Frkovic-Grazio, S [1 ]
Bracko, M [1 ]
机构
[1] Inst Oncol, Dept Pathol, SI-1105 Ljubljana, Slovenia
关键词
D O I
10.1136/jcp.55.2.88
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To determine the prognostic usefulness of the Nottingham histological grade (NHG) and its components in a series of 270 patients with stage pTINOMO breast cancer with a median follow up of 12.5 years. Methods: Microscopic slides were re-examined and the degree of tubule formation, nuclear pleomorphism, and mitotic counts were assessed and scored according to the suggested guidelines. The association with cancer specific survival (CSS) was evaluated by univariate and multivariate analyses. Results: Whereas tumour size, patient age, menopausal status, type of surgery, or adjuvant treatment were not related to prognosis, histological type (p < 0.01) and NHG (p < 0.005) were associated with CSS. When evaluating the components of NHG separately, survival was not related to the score for pleomorphism, but was significantly better in tumours with score 1 or 2 for tubule formation (p < 0.007) and in those with score 1 for mitotic counts (p < 0.006). The two components retained independent significance in multivariate analysis. When the proposed cut off points for mitotic counts were replaced by lower ones based on fertile values, the mitotic index became the strongest prognostic factor (p = 0.0001) and histological type was the only additional factor of independent prognostic significance. Conclusions: These findings confirm the prognostic value of NHG in pTINOMO breast carcinoma, show that the evaluation of tubule formation and mitotic rate provides independent prognostic information, and suggest that the proposed cut off points for mitotic counts may be too high for this particular group of tumours.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 49 条
  • [1] Abner AL, 1998, CANCER-AM CANCER SOC, V83, P2502, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2502::AID-CNCR14>3.3.CO
  • [2] 2-9
  • [3] DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS
    ALTMAN, DG
    LAUSEN, B
    SAUERBREI, W
    SCHUMACHER, M
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) : 829 - 835
  • [4] THE NOTTINGHAM-PROGNOSTIC-INDEX APPLIED TO 9,149 PATIENTS FROM THE STUDIES OF THE DANISH-BREAST-CANCER-COOPERATIVE-GROUP (DBCG)
    BALSLEV, I
    AXELSSON, CK
    ZEDELER, K
    RASMUSSEN, BB
    CARSTENSEN, B
    MOURIDSEN, HT
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (03) : 281 - 290
  • [5] Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up
    Barbareschi, M
    Caffo, O
    Veronese, S
    Leek, RD
    Fina, P
    Fox, S
    Bonzanini, M
    Girlando, S
    Morelli, L
    Eccher, C
    Pezzella, F
    Doglioni, C
    Palma, PD
    Harris, A
    [J]. HUMAN PATHOLOGY, 1996, 27 (11) : 1149 - 1155
  • [6] The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables
    Bergers, E
    Jannink, I
    vanDiest, PI
    Cuesta, MA
    Meyer, S
    vanMourik, JC
    Baak, JPA
    [J]. HUMAN PATHOLOGY, 1997, 28 (01) : 95 - 100
  • [7] HISTOPATHOLOGIC HIGH-RISK FACTORS INFLUENCING THE PROGNOSIS OF PATIENTS WITH EARLY BREAST-CANCER (T1N0M0)
    BILIK, R
    MOR, C
    WOLLOCH, Y
    DINTSMAN, M
    [J]. AMERICAN JOURNAL OF SURGERY, 1986, 151 (04) : 460 - 464
  • [8] Boiesen P, 2000, ACTA ONCOL, V39, P41
  • [9] CHAITCHIK S, 1987, EUR J SURG ONCOL, V13, P499
  • [10] DAVIS BW, 1986, CANCER-AM CANCER SOC, V58, P2662, DOI 10.1002/1097-0142(19861215)58:12<2662::AID-CNCR2820581219>3.0.CO